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Abstract.  Gelsolin is a  Ca  2+- and polyphosphoinosi- 
tide-modulated actin-binding protein which severs ac- 
tin filaments, nucleates actin assembly, and caps the 
"barbed" end of actin filaments. Proteolytic cleavage 
analysis of human plasma gelsolin has shown that the 
NH2-terminal half of the molecule severs actin fila- 
ments almost as effectively as native gelsolin in a 
Ca2+-insensitive but polyphosphoinositide-inhibited 
manner. Further proteolysis of the NH2-terminal half 
generates two unique fragments (CT14N  and CT28N), 
which have minimal severing activity. Under physio- 
logical salt conditions, CT14N  binds monomeric actin 
coupled to Sepharose but CT28N does not. In this pa- 
per,  we show that CT28N binds stoichiometrically and 
with high affinity to actin subunits in filaments, sug- 
gesting that it preferentially recognizes the conforma- 
tion of polymerized actin. Analysis of the binding data 
shows that actin filaments have one class of CT28N 
binding sites with Kd  =  2.0  ￿  10  -7 M, which saturates 
at a CT28N/actin subunit ratio of 0.8. Binding of 
CT28N to actin filaments is inhibited by phosphatidyl- 
inositol 4,5-bisphosphate micelles.  In contrast, neither 
CT14N  nor another actin-binding domain located in 
the COOH-terminal half of gelsolin form stable stoi- 
chiometric complexes with actin along the filaments, 
and their binding to actin monomers is not inhibited 
by PIP2.  Based on these observations,  we propose that 
CT28N  is the polyphosphoinositide-regulated actin- 
binding domain which allows gelsolin to bind to actin 
subunits within a filament before severing. 
ELSOLIN is a multifunctional actin binding protein of 
mammalian cytoplasm and  extracellular fluids.  It 
can  interact with actin in at least three  ways (re- 
viewed in Stossel et al., 1985). First, it binds to actin mono- 
mers and oligomers to promote actin nucleation. Second, it 
blocks the "barbed" end (with reference to the orientation of 
heavy meromyosin arrowheads) of actin filaments, prevent- 
ing monomer exchange from that end. Third, it severs actin 
filaments by nonproteolytically breaking actin-actin bonds 
between adjacent actin molecules. Each gelsolin can cause 
a  single break within a filament, suggesting that there is a 
stoichiometric interaction between gelsolin and actin mole- 
cules within a filament before severing (Yin et al., 1980; Jan- 
mey et al., 1986a, b). Once the filament is severed, gelsolin 
remains bound to the barbed end of the filament, preventing 
reannealing. Severing is activated by micromolar Ca  2+ (Yin 
and Stossel,  1979; Bryan and Kurth,  1984; Janmey et al., 
1985;  Bryan and Coluccio,  1985) and inhibited by phos- 
phatidyl inositol 4,5 bisphosphate (PIP2) ~  and phosphatidyl 
inositol monophosphate (Janmey and Stossel, 1987, Janmey 
et al., 1987). Although the interaction of gelsolin with actin 
is  strongly Ca  2+ dependent,  complete reversal  of binding 
was not observed after chelation of Ca  2+ with EGTA.  Only 
one of the two actins bound to gelsolin dissociates, resulting 
1. Abbreviation used in this paper: PIP2, phosphatidyl inositol 4,5 biphos- 
phate. 
in a  1:1 EGTA-resistant  gelsolin-actin complex (Kurth and 
Bryan, 1984; Janmey et al., 1985) which does not sever actin 
filaments.  The  complex  can  be  dissociated  with  PIP2 
micelles, and severing activity is restored after disruption of 
micelles with nonionic detergents. These data suggest that 
gelsolin may be regulated by a two signal mechanism involv- 
ing changes in Ca  2§  and polyphosphoinositide concentra- 
tions, and may have a critical role in mediating the reorgani- 
zation of the cytoskeleton after agonist stimulation of cells 
(Chaponnier et al.,  1987; Lind et al.,  1987). 
We and others have sought to understand the structural ba- 
sis for the many functions of gelsolin and its complex regula- 
tion. One approach has been to examine the actin binding 
and  functional properties  of proteolytically derived  frag- 
ments of human plasma gelsolin,  and their regulation by 
Ca  2+  or  polyphosphoinositides. The  primary  structure  of 
human plasma gelsolin (previously called actin-destabilizing 
factor or brevin [Chaponnier et al.,  1979; Norberg et al., 
1979; Harris et al., 1980; Harris and Schwartz, 1981]) is iden- 
tical to that of cytoplasmic gelsolin, with the exception of a 
25-amino acid extension at the NH2  terminus (Yin  et al., 
1984; Kwiatkowski et al., 1988), so we shall refer to it as gel- 
solin. The actin filament (F-actin)-severing domain of gelso- 
lin has been localized to the NH2-terminal half of the mole- 
cule  (Kwiatkowski et  al.,  1985; Bryan  and  Hwo,  1986; 
Chaponnier et al., 1986; Rouayrenc et al., 1986). A 45-kD 
NH2-terminal  peptide derived by digesting human plasma 
￿9  The Rockefeller University Press, 0021-9525/88/03/805/8 $2.00 
The Journal of Cell Biology, Volume 106, March  1988 805-812  805 gelsolin with chymotrypsin or thermolysin severs actin fila- 
ment almost as effectively  as intact gelsolin (Bryan and Hwo, 
1986; Chaponnier et al.,  1986). Severing by the NHz-ter- 
minal half fragment is inhibited by PIP2 (Janmey and Stos- 
sel,  1987; Janmey et al.,  1987), but Ca  ~+ is no longer re- 
quired.  Ca  z+  regulation of the  intact  gelsolin appears  to 
reside  in the COOH-half of the molecule that exhibits a 
Ca2+-dependent  conformational change  (Hwo and Bryan, 
1985;  Kwiatkowski  et  al.,  1985) and  contains  a  Ca  2+- 
sensitive actin-binding domain (Kwiatkowski et al.,  1985). 
These observations led to several models for the interaction 
of the two halves of gelsolin to account for the stringent 
Ca  z+  requirement of gelsolin's  severing  function, and the 
persistence of monovalent actin-gelsolin complexes when 
EGTA  is  added  subsequent  to  Ca  z+  activation  of gelso- 
lin-actin binding (Kwiatkowski et al., 1985; Bryan and Hwo, 
1986; Chaponnier et al.,  1986, Janmey et al.,  1986b). 
Further  proteolytic  digestion  of the  NH2-terminal  half 
yields two major species, a 17-14-kD doublet from the NH2 
terminus (amino acid residues 1-150/24-150 of  plasma gelso- 
lin,  deduced from amino acid sequence analysis and the 
cDNA sequence shown in Kwiatkowski et al.,  1986) and a 
28-kD fragment encompassing residues  151-406 (Table I). 
CT14-17N binds actin coupled to Sepharose,  inhibits actin 
polymerization and accelerates  the depolymerization of F-ac- 
tin with kinetics consistent with severing (Kwiatkowski et 
al., 1985). Its severing activity however is weak, being ,'~1% 
as effective as CT45N on a molar basis. Therefore, an addi- 
tional domain in  the  NH2  terminus may be  necessary to 
account for the potent severing activity of CT45N. In this pa- 
per,  we report that CT28N (referring to the 28-kD chymo- 
tryptic fragment derived from the NHz terminus; formerly 
called CI30N because it has an apparent mobility of 30 kD 
on  an  SDS-polyacrylamide gel)  binds  stoichiometrically 
and with high affinity to actin molecules within a filament 
(see Table I). Binding of CI~8N to actin is more sensitive 
to  inhibition by PIP2  than CT14N,  CI'45N,  and  Cq38C. 
CT28N  itself does not sever actin filaments. Because the 
severing function of gelsolin is likewise more sensitive to in- 
hibition by PIP2 than other gelsolin functions examined, we 
propose that C-q28N is the actin binding domain that allows 
gelsolin or CT45N to bind to the side of  actin filaments before 
severing.  A  similar fragment has been identified by Bryan 
(1988). 
Materials and Methods 
Gelsolin Preparation 
Human plasma gelsolin was purified in two steps: affinity chromatography 
over a  monoclonal antibody (2C4) column (Chaponnier et al.,  1986) and 
further  purification by  DEAE-Sepharose  ion  exchange chromatography. 
The gelsolin concentration was estimated using an extinction coefficient, 
EM  2~~ of 117,580 M -~  cm-', calculated from the number of tyrosine and 
tryptophan residues present in the human plasma gelsolin (Kwiatkowski et 
al.,  1986).  The EM  28~ for tyrosine and tryptophan are 1,390 and 5,800 M-' 
cm  -t, respectively, taking an average between that for exposed and buried 
residues (Magne et al.,  1977). The gelsolin was >99% pure, as judged by 
Coomassie Blue staining of SDS-polyacrylamide gels.  108 ~g of gelsotin 
was iodinated with 0.5 mCi '251 by the Bolten Hunter procedure (Amer- 
sham kit; Amersham Corp., Arlington Heights, IL), as described by Harris 
(1985).  lodinated  gelsolin was  separated  from  unincorporated Nal2SI by 
passage through a Sepharose G-25 column equilibrated with 10 mM Tris- 
HCI,  pH  8.0,  0.1  M  NaCI,  5  mM  MgCI:,  1 mg/ml gelatin  (Bio-Rad 
Laboratories, Richmond, CA) and dialysis against TBS-EGTA. The specific 
Table L Properties  of Gelsolin Peptides 
Parameters  Gelsolin  CT45N  CTI4N  CT28N  CT38C 
Residues*  1-756  1-496  24-150  151-406  407-756 
Molecular mass 
(xlO  -3)  83.0  44.8  14.3  28.2  38.2 
Ca  -'+ activation  +  -  -  -  + 
PIP2  inhibition  +  +  -  +  - 
Monomer binding  +  +  +  -  + 
Filament binding  +  +  -  +  - 
Nucleation  +  +  -  -  - 
Severing  +  +  ?11  -  - 
Capping  +  +  ?w  ?w  ?w 
In the presence of Ca  -'+, gelsolin is cleaved into four major groups of peptides 
by chymotrypsin (Kwiatkowski  et al.,  1985; Bryan and Hwo,  1986; Chapon- 
nier et al.,  1986).  These peptides are designated CT, followed by molecular 
mass (determined from deduced amino acid sequence), and either N or C, to 
denote their origin from the NH2- or COOH-terminal half of the molecule. 
+, responds to or active;  -, does not respond or inactive. For the sake of sim- 
plicity, the different  degree of response/activity is not indicated. 
* Amino acid residues, numbered from the NHz terminus. The origin of the 
peptide was determined by amino acid sequencing, and their location in the 
protein deduced from cDNA data (Kwiatkowski et al.,  1985~ 1986). 
~t Gelsolin and CT38C migrated with slower mobility on SDS-polyacrylamide 
gels than expected  from their mass (as 93- and 47-kD bands). The reason for 
the anomalous mobility is not known. 
II Only  1%  of the severing activity  of CT45N  or  intact  gelsolin.  See  dis- 
cussion. 
w  Kwiatkowski  et  al.  (1985)  showed  that  there  is  no  change  in  critical 
monomer concentration in the presence of these peptides. However, only high 
affinity capping proteins are expected to cause detectable  changes in monomer 
concentration, so that weak capping activity would not be detected  by measur- 
ing changes in critical  monomer concentration at steady state. 
activity was 0.9 ~tCi/~tg, or  1 mol ~z51  per 24 mol gelsolin. Autoradiogra- 
phy of the labeled gelsolin confirmed that >99% of the radioactivity was 
associated with the 93-kD gelsolin band, and a small amount of label was 
associated with a 40-kD band that did not bind actin. 
To prepare  ~25I-labeled gelsolin peptides, 5.4 I.tg of u251-1abeled gelsolin 
was mixed with 542 ~tg unlabeled gelsolin (0.55 mg/ml) and digested with 
4  gg of c~-chymotrypsin (CooperBiomedical, Inc., Malvem, PA) (gelso- 
lin/chymotrypsin weight ratio of 136:t) in 10 mM Tris-HCI, pH 7.4, 1 mM 
EGTA,  1.5 mM CaCI2, and 2 mM MgCt2.  Digestion was allowed to pro- 
ceed for 30 min at room temperature, and the reaction was stopped by addi- 
tion of phenylmethyl sulfonyl fluoride to a final concentration of 2 mM. The 
mixture of peptides was fractionated in either of two ways. 
(a)  To separate NH2-terminal and COOH-terminal half derived pep- 
tides, the digest was passed over a  2-ml monoclonal anti-gelsolin (2C4) 
column that is specific for an epitope in the COOH-terminal half of gelsolin 
(Chaponnier et al.,  1986).  The adherent and nonadherent peptides were 
analyzed by SDS-PAGE and radiolabeled bands were detected by autoradi- 
ography in the presence of a Cronex enhancing screen (Dupont Co., Wil- 
mington,  DE).  On  SDS  gels,  the  nonadherent  material,  designated 
NH2-terminal half peptide mix, contains a  mixture of 45-,  30-,  17-, and 
15-kD bands, which have been shown by amino acid sequencing and immu- 
noblotting to be derived from the NH2-terminal half of gelsolin. The ad- 
herent fraction contains a 47-45-kD doublet, a 28- and a 15-kD peptide. The 
former peptides have been shown by amino acid sequencing to be derived 
from the COOH-terminal half of gelsolin (formerly called CT47C [Kwiat- 
kowski et al.,  1985],  now called CT38C;  Table I). 
(b) To isolate CT28N, we took advantage of the fact that the peptide binds 
actin-Sephamse in a solution of low ionic strength, containing 0.5 mM ATE 
0.5 mM 2-mercaptoethanol, 0.2 mM CaC12, and 2 mM Tris-HC1, pH 7.5, 
but is eluted with 0.15 M  KC1 (Kwiatkowski et al.,  1985).  Actin was pre- 
pared from rabbit skeletal muscle by the method of Spudich and Watt (1971) 
and coupled to cyanogen bromide-activated Sepharose CL4B as described 
in Kwiatkowski et al., 1985. The chymotryptic digest of gelsolin was passed 
through a  1.5 ml actin-Sepharose column equilibrated with buffer A. The 
beads  were  washed with  20  vol of buffer A  (2  mM Tris-HC1,  pH  7.6, 
0.2 mM CaClz, 0.2 mM 2-mercaptoethanol, 0.2 mM ATP) and eluted with 
the same buffer solution containing 0.15 M KCI. The eluted sample was ana- 
lyzed by SDS-PAGE and shown to contain >90% 30-kD band and some 47- 
and 45-kD bands. The bulk of the 47-kD polypeptide (Cq38C) was removed 
by passing through a 2C4 column. The CT28N samples used here are the 
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et al., 1985), because it was isolated by the same procedure, and recognized 
by the same panel of monoclonal antibodies. These preparations contain a 
small amount (<5 %) ofa 45-kD band, part of  which is due to CT45N (based 
on antibody cross-reactivity). 
The concentrations of CT45N and CT28N were determined by calculat- 
ing  the  theoretical  extinction coefficient as  described above.  EM  2s~ foi 
CT45N  and C'I28N  are 50,090  and 28,760  M -1  cm  -1,  respectively. The 
concentration of the NHz-terminal peptide mix was determined using the 
EM  2s~ for CT45N,  and expressed as mg/ml. 
Actin-binding Assays 
Cosedimentation  with F-Actin.  This assay has been described for ~25I-pig 
plasma gelsolin by Harris (1985).  Actin for these studies was gel-filtered 
through a Sephadex G150 column, and its concentration determined using 
EM  29~ =  26,655  M -~ cm  -I. Actin (1.67  ￿  10  -4 M) was polymerized by ad- 
dition of KCI and MgCI2 to 0.15 M and 2 mM, respectively. The actin was 
added to  )25I-labeled gelsolin or gelsolin fragments in  100  txl of 0.15 M 
KC1, 2 mM Tris-HCl, pH 7.6, 0.5 mM ATP, 0.1% gelatin, and either 0.2 
mM CaCI2 or  1 mM EGTA for 30  min at 37~  The reaction mixtures 
were centrifuged at 20 psi in an airfuge for 30-60 min, and radioactivity 
in the supernatant fluid and pellet was determined in a gamma counter. The 
supernatant and pellet were boiled in equal volumes of gel sample buffer, 
and the same amount of  each was subjected to electrophoresis  on SDS-poly- 
acrylamide slab gels. Radioactive bands were detected by autoradiography. 
Binding  to Actin-Sepharose.  NH2-terminal half peptide mix (at a con- 
centration equivalent to 0.15 IxM CT45N;  9,000  cpm) was incubated with 
actin-Sepharose beads in 10 mM Tris-HCl, pH 7.5, 0.15 M KCI, 0.2 mM 
CaCI: (TBS-Ca  2+) containing 0.13%  Triton X-100. After a 45-min incuba- 
tion at 4~  the beads were sedimented by centrifugation for 1 min, and 
washed with 0.1%  Triton X-100 solution. The beads were resuspended in 
the same buffer, sedimented once more, and counted in the gamma counter. 
Samples of the first supernatant and washed beads were analyzed by SDS- 
PAGE and autoradiography. 
Binding to Actin Complexed to DNaseI-Beads.  DNaseI was coupled to 
cyanogen-bromide-activated Sepharose beads according to the manufac- 
turer's direction (Pharmacia  Inc.,  Piscataway,  NJ).  125I-labeled NHz-ter- 
minal peptide mix (0.049 jaM CT45N equivalent; 2100 cpm) were incubated 
with 1.2  x  10  -7 M actin in 300 jal of TBS-EGTA containing 0.1% gelatin 
for  15  min at room temperature.  30  )11 of a 50%  (vol/vol) suspension of 
DNase beads was added and incubation was continued for 1.5 h at 4~  The 
beads were sedimented and washed with TBS-CaCI2  containing 0.1% Tri- 
ton X-100. Nonspecific binding was assessed by omission of actin. 
Preparation of  Phospholipids 
PIP2, purchased from Sigma Chemical Co., St. Louis, MO, was mixed with 
water to a final concentration of I mg/ml and sonicated for 30 sec at maxi- 
mum power in a sonicator (model Wl85;  Heat Systems-Ultrasonics, Inc., 
Farmingdale, NY). The suspension was frozen in 0.2 ml aliquots at -70~ 
The lipid solution was quickly thawed in warm water and sonicated in a wa- 
ter bath sonicator for 30 min immediately before use. In some cases, the 
PIP2 suspension was examined by quasielastic light scattering. 
Interaction of  Peptides with Pyrene-labeled  Actin 
G-actin  was  labeled  with N-(1-pyrenyl)iodoacetamide by  the  method of 
Kouyama and Mihashi (1981). The relative amounts of G- and F-actin and 
the rate of change were determined as described in Janmey et al.  (1985). 
The buffer used contains 2  mM  MgC12, 0.5  mM ATP,  0.2  mM CaCI2, 
150 mM KCI, and 20 mM Tris-HCl, pH 7.5 (buffer B). The rate of actin 
polymerization in the presence of gelsolin has been shown to be propor- 
tional to the gelsolin concentration (Doi and Frieden, 1984; Coue and Korn, 
1985; Janmey and Stossel, 1986), and when actin filaments are diluted to 
below the critical  monomer concentration, the depolymerization rate  is 
proportional to the number of filament ends created by gelsolin (Bryan and 
Coluccio,  1985; Janmey and Stossel, 1986). 
Results 
Identification of  F-Actin-binding Gelsolin Peptides 
Fig.  1  A  shows  that  t25I-labeled  human  plasma  gelsolin 
binds F-actin in the presence of Ca  2+ but only minimally in 
Figure L Binding of gelsolin and gelsolin  peptides to F-actin. (A) 
~25I-labeled  gelsolin (0.0026  ~tM) was incubated with  13 BM F-ac- 
tin in 100 I.tl of 0.15  M  KCI, 2 mM Tris-HCl, pH 7.6, 0.5 mM ATP, 
0.1% gelatin, and either 0.2 mM CaC12 or 1 mM EGTA for 30 rain 
at 37~  The reaction mixtures were centrifuged at 20 psi in an air- 
fuge for 40 min and radioactivity in the supernatant and pellet were 
determined in a gamma counter. Equivalent volumes of the samples 
were subjected to electrophoresis on SDS-polyacrylamide gel, and 
radioactive bands were detected by autoradiography with a Cronex 
enhancing screen (Dupont Co.). S, supernatant; P, pellet; G, gelso- 
lin, which has an apparent mobility of 93 kD.  O, in 0.2  mM CaCI2 
and without actin;  C,  in 0.2  mM CaC12;  E,  in  1 mM EGTA.  (B) 
NH2-terminal  peptides  (a  mix  of CT45N,  CT28N,  and  CT14N, 
equivalent  to 0.16  IxM  of cr45N)  were  incubated with  12.8  I~M 
F-actin.  The molecular masses of peptides, in kilodaltons,  deter- 
mined by comparison with standards on SDS gels, are indicated on 
the right. 
its absence.  These results  are consistent with previous data 
using unlabeled rabbit macrophage and human  plasma gel- 
solin (Yin and Stossel,  1979; Janmey et al., 1985),  but differ- 
ent from that with pig plasma gelsolin (Harris,  1985) which 
is  also  less  stringent  in  its  Ca  2+  requirement  functionally 
(Weeds  et  al.,  1986).  Autoradiography  of the  125I-gelsolin 
shows that the major band is 93 kD, and there is a minor con- 
taminant of'~40 kD which does not cosediment with F-actin 
(Fig.  1 A, lane O). In the presence of 0.2 mM CaCI2, a large 
proportion of gelsolin cosedimented with F-actin (Fig.  1 A, 
lanes C). Gamma counting of the pellets showed that 82 % of 
the input gelsolin radioactivity  was recovered in the presence 
of Ca  2+, and only  10%  pelleted in the presence of EGTA. 
Similar amounts of actin were sedimented, as judged by the 
intensity  of the Coomassie Blue-stained  actin band  in the 
pellet and supernatants.  The small amount of gelsolin left in 
the  supernatant  in  Ca  2+  was  most  likely  bound  to  actin 
oligomers that were too short to be sedimented. Sedimenta- 
tion without actin pelleted 5%  of the radioactivity,  part of 
Yin et al.  Gelsolin/Ca2§  Severing  807 Figure 2.  Binding  of CT28N to actin  filaments,  t25I-labeled CT28N was incubated  with  F-actin  in 80 ~tl of buffer B for 30 min at room 
temperature.  The reaction mixtures were centrifuged for 1 h in an airfuge at 23 psi.  Radioactivity  associated  with the supernatants  and 
pellets  were determined  in a  gamma counter,  and equivalent  aliquots  of the  samples  were  analyzed by SDS-PAGE.  (A) Coomassie 
Blue-stained gel of supernatant  (S) and pellet  (P) fractions of CT28N incubated  with 2.2 p.M F-actin.  Lanes 1-4, 0.94,  1.98, 2.84,  and 
3.78 ~tM CT28N,  respectively.  Lane 4', loaded with two-thirds  as much sample as in lane 4 to assess  the linearity  of the assay. A, actin. 
(B) Moles of CT28N bound per mole of sedimented  actin was plotted  as a function  of free CI28N concentration, in micromolars.  The 
data represent average of  duplicate determinations  from three separate experiments,  in which either 0.8 or 2.2 ~tM actin was used. Densitom- 
eter scanning reveals that 17 and 12 % of  actin are in the supernatants,  respectively, indicating a critical concentration of  actin polymerization 
of  0.14-0.27 I.tM, consistent with known values for actin in the absence of gelsolin.  (Inset) Autoradiogram of pelleted CT28N when 0.t8-1.2 
~M of CT28N was added to 0.8 ~tM F-actin. (C) Scatchard  plot of gelsolin  binding to actin in filaments.  Bound CT28N was expressed 
as moles of CI28N per mole of sedimented  actin subunits.  Free CI28N concentration was expressed  in micromolars.  The line was fitted 
by linear regression analyses and the coefficient of correlation was -0.91. It intercepted the x-axis at 0.85 mol CT28N per mol actin. (Down- 
ward triangles) experiment  using 2.2  IxM actin;  (upward triangles and circles) experiments  using 0.8 ~tM actin. 
which may be attributed  to residual  supernatant  and non- 
specific sticking of ~25I-gelsolin to the side of the tube. 
Fig.  1 B  shows an  autoradiogram  of NH~-terminal  half 
peptides that have been centrifuged in the presence of F-ac- 
tin. The bulk of CT45N and Cq28N cosedimented with actin 
(Fig.  1 B, lane PC), while most of CT14-17N remained in the 
supernatant  (lane SC).  A  similar  pattern  was observed  in 
EGTA (Fig. 1 B, lanes SE and PE). These results demonstrate 
that CT45N and CT28N form stable complexes with F-actin 
in a  Ca2§  manner,  while CTI4-17N does not. 
Cosedimentation of gelsolin and its fragments with F-actin 
may reflect binding along the length of the filament  (side 
binding) as well as to the end of a  filament.  Since gelsolin 
and C1~45N sever actin filaments stoichiometrically, the spe- 
cies that cosediment with F-actin are most likely located at 
the barbed end of the newly severed actin filaments that are 
sufficiently long to be sedimented (note low ratios of gelso- 
lin-actin and CT45N-actin used).  The quantitative cosedi- 
mentation of CT28N with F-actin, however, is more likely to 
result from binding to the side of actin filaments,  because 
CT28N has minimal actin severing activity (Kwiatkowski et 
al.  1985; also see below). The lack of binding of CTI4-17N 
suggests either that they do not bind to the side of the fila- 
ments, or if they do, the complex is not stable.  However, it 
does not rule out binding to the end of filaments,  because 
CT14-17N does not sever filaments well, and the number of 
unoccupied barbed  ends  is  small  so  little  binding  is  pre- 
dicted.  The question of whether CT14N caps actin filament 
ends is not settled.  Our previous functional studies indicate 
that CT14N does not cap actin filaments with sufficiently high 
affinity to increase the critical monomer concentration (Kwi- 
atkowski et al.,  1985; however also see Table I). 
Binding of CT28N to Actin Filaments 
To examine further the interaction of CT28N with actin fila- 
ments, increasing amounts of purified CF28N were added to 
F-actin, and binding was monitored by the cosedimentation 
The Journal of Cell Biology, Volume  106, 1988  808 Figure 3. Effect of PIP2 on the binding  of gelsolin and gelsolin peptides  to F-actin.  ~25I-labeled  gelsolin or fragments  were incubated  with 
12.1 tam F-actin (a-c) or actin-Sepharose (d) in the presence of PIP2 as described  in Materials  and Methods.  (a) 0.00026 ~tM ~25I-labeled 
gelsolin  was centrifuged with  F-actin  in the presence of 0,  14, 42,  70,  and  98  txM PIP2 respectively  in a buffer containing  0.15 mM 
CaC12/0.1 mM EGTA. Equivalent  aliquots  of supematant (S) and pellet  (P) were analyzed by autoradiography  (after  solubilization  with 
SDS-gel sample buffer and PAGE on a slab gel), and the intensity of the gelsolin band was determined by densitometer  scanning.  Similar 
results  were obtained  by determining  radioactivity  in a gamma counter.  In the absence of PIP2, 80%  of geisolin  was sedimented.  PIP2 
decreased the sedimentable  gelsolin  without changing the amount of sedimentable  actin (data not shown).  G, gelsolin.  (b) The amount 
of sedimentable  gelsolin  or ~25I-labeled CT28N  in the presence of PIP2 was expressed  as percent of that  sedimented  in its absence,  and 
plotted as a function of PIP2 concentration. The data for gelsolin  was derived  from experiment shown in a by gamma counting.  The data 
for CT28N was obtained by cosedimenting purified  ~25I-labeled CI28N (0.18 IxM) with actin in the presence of 1.0 mM EGTA. Radioactiv- 
ity was determined by gamma counting,  and 100% of the input CT28N was sedimented  in the absence of PIP2. (c) 0.16 p.M of ~25I-NH2- 
terminal  half peptide  mix was incubated  with  F-actin  in the presence of 0, 4.4,  13.7, and 27 ~tM PIP2 (lanes  1-4,  respectively).  In the 
absence of PIP2,  100% of CT28N and 67%  of CT45N were sedimented.  The pelleted  peptides  were analyzed by autoradiography.  The 
ratios  of sedimented  CT28N to CT45N,  determined  by densitometry,  changed  from 1.1 to 0.71, 0.46, and 0.36 with  increasing  amounts 
of PIP2. (d) ~25I-NH2-terminal peptides  (equivalent  to 0.22 ~tM CT45N)  were incubated  with 75 I~1 of packed actin-Sepharose beads in 
the presence of TBS-0.2  mM CaC12. The beads  were washed  with TBS-EGTA,  divided  into five aliquots,  and incubated  with 0.5 ml of 
solutions  containing  increasing  amounts  of PIP2  in  the  presence  of 1 mM  EGTA.  (Inset)  NH2-terminal  peptides  remaining  on  ac- 
tin-Sepharose after incubation  with 0, 0.22, 0.44,  0.88, and 1.76 mM PIP2 (lanes 1-5, respectively).  Radioactivity  associated  with CT45N 
(which was resolved  into two bands in this experiment)  and CT17-15N was determined by cutting the bands from the gel and counting in 
a gamma counter.  In the absence of PIP2, 540 and 180 cpm were associated  with CT45N and CT17-15N, respectively.  The amount of each 
peptide  sedimented  in the presence of PIP2 was expressed  as a percent of control. 
assay. Fig. 2 A shows a Coomassie Blue-stained gel of super- 
natant and pellet fractions.  CT28N cosedimented with F-ac- 
tin  and  saturation  of binding  was observed  when  2.9  ~tM 
CT28N was added to 2.2  laM actin (Fig.  2 A, lanes 3).  At 
saturation, the molar ratios of CT28N to actin in the pellet, 
determined by densitometric scanning of lanes 3 and 4, were 
0.80 and 0.84,  respectively.  A  similar  ratio  (0.81)  was ob- 
tained with less sample was loaded on the gel (Fig. 2 A, lane 
4'), confirming the linearity of  the assay. The amount of actin 
sedimented remained  constant (82  +  5%) as judged by its 
intensity in the supernatant  and pellet fractions.  A  1.7-fold 
molar excess of CT28N to actin did not decrease the amount 
of sedimentable  actin  significantly,  suggesting that C-q28N 
does  not  sever  actin  filaments  nor depolymerize  them  by 
binding  to  actin  monomers.  Direct  measurement  of actin 
severing, using a fluorimetric assay, showed that CT28N (not 
iodinated)  contained  <10%  of the  severing  activity  of an 
equivalent amount of intact gelsolin or CT45N,  which can 
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binding of CI28N to actin monomers within a filament sug- 
gests that CT28N binds stoichiometrically to actin along the 
length of actin filaments. 
Additional binding experiments using a wider concentra- 
tion range of ~25I-CI28N and two different concentrations of 
actin were performed, Fig. 2 B shows that binding of ~25I- 
CT28N to F-actin is saturable. The Fig. 2 B, inset shows an 
autoradiogram of CI28N in the pelleted fraction, to demon- 
strate  the  purity  of the  CI28N  preparation  and  confirm 
saturable binding of CT28N.  Analysis of the binding data 
shown in Fig. 2 B by the method of Scatchard (1949) suggests 
one class of C-q28N binding sites on actin,  which became 
saturated when 0.85 mol of C-q28N was bound to each mole 
of actin subunit in the filaments (Fig. 2 C). Since the Scatch- 
ard method is not strictly applicable to the sedimentation as- 
say presented here (the concentration of  actin, the "receptor; 
is similar to that of CI28N, the ligand, so that the free ligand 
does not approximate total ligand), the dissociation constant 
was calculated directly from individual data point from the 
relation Ka  =  [free CI28N]  [free actin]/[complex] where 
[free CI28N]  =  [total CI28N]  -  [complex]; [free actin] = 
[total  actin]  -  [complex]; and [complex] was  taken as the 
amount of CT28N cosedimenting with actin divided by the 
initial volume. The result, Kd =  2.0  ￿  10  -7 M  +  0.8  ￿  10  -7 
M (n =  10). Three data points shown in Fig. 2 B were omitted 
because they gave Kd values considerably different from that 
of  the rest of the data points, reflecting large errors in the cal- 
culation of [free CV28N] at the plateau. If these points were 
included, Kd  =  2.8  ￿  10  -7 M  __+  1.9  x  10  -7 M  (n  =  13). 
Effect of PIP2 on Gelsolin and Gelsolin Peptide 
Binding to Actin 
Fig.  3 a  shows  that PIP2 decreases the amount of gelsolin 
that cosedimented with F-actin,  with a  corresponding in- 
crease in nonsedimentable gelsolin. The effect  of PIP2 on the 
percent of ~25I-gelsolin bound to F-actin from this experi- 
ment is plotted on Fig. 3 b. The amount of PIP2 required to 
inhibit gelsolin binding is much higher than that required to 
inhibit binding of CT28N, determined by cosedimentation 
of purified ~25I-CT28N with F-actin (Fig.  3 b).  Binding of 
CT28N to F-actin is also more sensitive to inhibition by PIP2 
than CT45N,  from which  it is  derived. This was demon- 
strated by studying the sedimentation of the NH2-terminal 
half peptide mix (Fig.  3 c). At the concentrations of PIP2 
used, the intensity of the CT45N band remained relatively 
constant while that of CT28N decreased. This difference is 
quantitated by taking the ratios CT28N/CT45N intensity (de- 
termined by densitometer scanning),  which decrease from 
1.1  to 0.4. 
Fig. 3 d examines the ability of PIP2 to inhibit binding of 
CI'14-17N to actin. Actin-Sepharose is used instead of actin 
filaments to bind the gelsolin fragments because CF14-17N 
does not bind detectably to actin filaments (see Fig.  1). As 
shown previously, in the presence of  0.15 M KC1, CT45N and 
CT14-17N bind actin-Sepharose but CT28N does not (Kwiat- 
kowski  et al.,  1985). PIP2 added to these complexes eluted 
more CT45N than CTI4-17N from the beads, suggesting that 
the  latter  is  less  sensitive to PIP2.  The elution curve for 
CT45N  is  similar  to  that  for EGTA-resistant gelsolin-ac- 
tin-Sepharose (data not shown), supporting the notion that 
PIP2  dissociates  EGTA-resistant gelsolin-actin  complexes 
through its effect on an NH2-terminal actin-binding site (Jan- 
me_y et al.,  1987). The high concentration of PIP2 required 
to cause dissociation of  gelsolin or cr45N is presumably be- 
cause protein-coated Sepharose beads  bind PIP2  nonspe- 
cifically (Janmey and Stossel,  1987; Iida, K.,  unpublished 
observation), decreasing the actual amount available to gel- 
solin. 
Janmey and Stossel (1987) have shown that the severing 
function of gelsolin is most sensitive to inhibition by PIP2 
whereas nucleation and capping are less so. Thus, both func- 
tional and binding data suggest that different actin binding 
domains with differential sensitivity to PIP2 mediate the sep- 
arate functions of gelsolin. The observations that PIP2 in- 
hibits most effectively gelsolin's severing function as well as 
the stoichiometric binding of CT28N to actin within a fila- 
ment suggest that PIP2 may inhibit gelsolin or CT45N sever- 
ing by preventing binding of the CT28N domain to the side 
of actin filaments. The smaller effect of PIP2 on binding of 
CT45N to filaments per se indicates that although CT45N can 
no longer bind to the side of the filaments (through CT28N), 
it can still  bind to the ends of actin filaments. 
Binding of  CT28N to Actin Monomers 
Fig. 4  shows that CT28N does not cosediment with mono- 
meric actin complexed with DNase-Sepharose in the pres- 
ence of a  solution containing 0.15 M  NaC1.  In contrast, a 
large proportion of  CT45N and C714-17N cosedimented with 
actin bound to DNase-Sepharose beads. The failure of CI28N 
to cosediment with actin complexed to DNase-Sepharose in- 
dicates that either CT28N does not bind stably to actin mono- 
mers at physiological salt concentrations, or that the CT28N- 
actin  complex cannot  bind  DNase-Sepharose  because  of 
steric hindrance or competition for the same binding site on 
actin. The latter alternative is unlikely because the amount 
of actin bound to DNase I beads is not decreased in the pres- 
ence of nonsedimentable CT28N (data not shown). The lack 
of association of CT28N to actin-DNase I and actin-Sepha- 
rose strongly suggests that C'I28N does not bind to mono- 
meric actin under physiological salt conditions, but preferen- 
tially binds F-actin. A lack of binding to monomeric actin 
is supported by our previous finding that C'I28N does not 
bind actin-Sepharose (Kwiatkowski et al.,  1985). 
Effect of PIP2 on NHrterminal Half Peptide Functions 
Fig.  5  shows  that PIP2 inhibits the severing and the weak 
nucleating activity of CT45N equally. Half maximal inhibi- 
tion was  observed at  3  mol of PIP2  micelle per  mole of 
Figure 4.  Binding of NH:-terminal pep- 
tides to actin complexed to DNaseI-Seph- 
arose. NH2-terminal peptides (0.05 ~tM) 
were incubated with actin (0.12 I~M) and 
then 15 ~tl DNase I-beads in buffer A con- 
raining 0.15 M KC1. The pellet (P) and su- 
pernatant (S) fractions were analyzed on 
SDS-PAGE, and radiolabeled  polypeptides 
detected by autoradiography. T, NH2-ter- 
minal peptides input. Actin  was quantita- 
tively recovered in the DNase-Sepharose 
fraction (data not shown). 
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￿9  ing  and  nucleation  by  the 
>.  80  ~  NH2-terminal  half  peptide. 
~~__~  CT45N was diluted to 0.11 IJM 
>  (for severing) or 0.15 ~tM (for  60 
o  nucleating)  in  buffer  B con-  < 
I--  40  mining  1 mM  EGTA. PIP2 
z  was added from a stock solu-  tu 
o  tion of 0.9 mM in water to the 
20  E  tu  final  concentrations  shown.  0. 
,  ~  t  After a 15-s incubation, either 
o  ts  ao  4s  60  F-actin (0.21 WVI) or G-actin 
PIP  2  (pM)  (4.1  gM) was added and the 
maximal  rate  of depolymer- 
ization (solid  circles)  or polymerization  (open  circles)  was mea- 
sured. The rates are relative to 100% for polymerization or depoly- 
merization  in the presence of the NH2-terminal half peptide and 
no PIP2. The rates for actin alone were 56% for polymerization and 
10% for depolymerization. 
NH2-terminal half fragment, a ratio similar to that reported 
for inhibition of severing by intact gelsolin (0.5:1),  but much 
lower than that for inhibition of nucleation by intact gelsolin 
(>3,200:1; Janmey and Stossel, 1987). The similarity in dose 
response for inhibition of severing by gelsolin and CT45N 
confirms that PIP2 acts on the NH2-terminal domain to in- 
hibit severing. On the other hand, the difference in the ability 
of CT45N and gelsolin to nucleate actin assembly (Chapon- 
nier et al.,  1986),  as  well as their  different  sensitivity to 
PIP2, show that the nucleating ability of gelsolin is modified 
by removal of the COOH-half domain.  Occupation of the 
COOH terminal site however is not sufficient by itself, be- 
cause CT38C does not nucleate actin assembly (Kwiatkowski 
et al.,  1985). 
Although  PIP2  inhibits  severing  and  nucleation  by  the 
NH2-terminal half, a third function, blocking of the barbed 
end  of actin  filaments,  is  less  affected.  Fig.  6  shows that 
CT45N, which is inhibited from severing actin filaments by 
PIP2, decreases the initial rate of depolymerization of F-actin 
after dilution (lefi) and reduces the initial rate of actin poly- 
merization to below that observed with actin alone (right). 
Furthermore, the final level of fluorescence attained at steady 
state is only slightly higher than that observed with CT45N 
in the absence of PIP2 (data not shown). These data suggest 
that the barbed ends of the filaments are blocked by CT45N 
in spite of inhibition of severing and nucleation by PIP2. 
In contrast to the results obtained with the NH2-terminal 
half peptide, PIP2 has little effect on CT38C. We have shown 
previously that Cq38C  (formerly called CT47C) decreased 
the initial rate and final level of polymerization to an extent 
consistent with the formation of stable 1:1 actin-CY38C com- 
plexes that cannot polymerize (Kwiatkowski et al.,  1985). 
The presence of 100 p,M PIP2 (a nearly equimolar ratio of 
micelles to Cq38C) did not change either parameter (data not 
shown), demonstrating that PIP2 does not inhibit the binding 
of CI38C to actin monomers. 
Discussion 
The data presented here show that human plasma gelsolin 
has at least three distinct actin binding sites (Table I), and 
identify a 28-kD peptide from the NH2-terminal half of gel- 
solin as the domain that binds to the sides of actin filaments, 
a step which may be required to account for the rapid stoi- 
chiometric severing of actin filaments by gelsolin (Yin et al., 
1980; Janmey et al.,  1986a). Previous proteolytic digestion 
studies  have  shown  that  the  45-kD  NH2-terminal  half of 
gelsolin severs actin filaments almost as effectively as intact 
gelsolin (Bryan and Hwo,  1986;  Chaponnier et al.,  1986), 
and that one of its actin binding domains is localized within 
CT14N (Kwiatkowski et al.,  1985).  It should be pointed out 
that although we have originally suggested that CT14N severs 
actin filaments (Kwiatkowski et al.,  1985),  its severing activ- 
ity is only 1% (on a molar basis) of that of intact gelsolin or 
CT45N.  Since we cannot rule out a  small (3 % by weight) 
contamination of our CT14N preparation with CT45N,  we 
are not certain whether CT14N can sever. It is, however, clear 
that  efficient  severing  requires  both  CT14N  and  another 
NH:-terminal  half  domain.  Our  present  data  show  that 
C'I28N has a role in promoting efficient severing by gelsolin: 
(a) CT28N binds stoichiometrically and with high affinity to 
actin molecules within a filament; (b) CT28N does not sever 
actin filaments, and neither does a 70-kD gelsolin fragment 
missing CT14N (Bryan, J.,  personal communications);  (c) 
CTI4N, which is required for severing, does not bind well 
(or stably) to the side of actin filaments and is relatively PIP2 
insensitive; (d) binding of C'I28N to F-actin and severing by 
gelsolin  are  inhibited  by  PIP2  with  comparable dose  re- 
sponse.  Since PIP2 inhibits Cq28N binding to F-actin and 
severing as well,  the simplest explanation is that PIP2 in- 
hibits severing by preventing CT28N binding to F-actin. 
The F-actin binding affinity of CT28N, determined here by 
direct binding assays,  is at least two orders  of magnitude 
lower  than  that  estimated  for gelsolin  (and  by  inference, 
CT45N) by severing function assays (5  x  106 M -~ and >109 
M -t,  respectively;  Coue  and  Korn,  1985;  Janmey  et  al., 
1985).  This difference suggests that there may be a high de- 
gree of interaction between CT28N and CT14N to increase 
the  affinity  of the  NH2-terminal  half domain  for  F-actin 
and maximally express the severing function. It is not clear 
whether CT28N and CT14N bind to the same or different ac- 
tin subunit. Since Cq28N binds preferentially to filamentous 
actin, it presumably recognizes an epitope or conformation 
found on F-actin only. It follows that CTI4N, which binds ac- 
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l~gure 6. cr45N blocks mono- 
mer exchange  from the  fast 
growing  filament end  in  the 
presence  of PIP2.  (Left') The 
initial time course of actin de- 
polymerization  is  shown for 
actin diluted in the presence of 
CT45N in the absence  (solid 
circles) or presence of 22 ~tM 
PIP2  (solid  triangles).  The 
rate for actin alone in the pres- 
ence of PIP2 is shown (open 
circles),  and is indistinguish- 
able from that in the absence 
of PIP2.  (Right)  The  initial 
rate of polymerization of actin in the presence of CT45N in the pres- 
ence (solid triangle)  and absence (solid  circles)  of 22 I.tM PIP2, 
compared with that of actin alone (open circles).  Reaction condi- 
tions are as described  for Fig. 5. 
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should recognize another conformation, presumably a dif- 
ferent site on actin that is not influenced by the state of poly- 
merization but is not accessible on F-actin. Recent chemical 
cross-linking  studies using G-actin-gelsolin  complexes by 
Doi et al.  (1987)  suggest that gelsolin binds to the first  12 
amino acids at the NH2 terminus of actin, but there is no in- 
formation on which actin binding domains are cross-linked 
to actin  under those circumstances. 
Although the COOH-terminal half of gelsolin does not ap- 
pear to contribute to severing of gelsolin, except conferring 
Ca  ~+ sensitivity (Kwiatkowski et al., 1985; Hwo and Bryan, 
1986; Chaponnier et al., 1986), our current data indicate that 
it contributes significantly to the nucleating activity of intact 
gelsolin. This conclusion is based on the following reason- 
ing:  (a) CT45N has only  10% of the nucleating activity of 
intact gelsolin (Chaponnier et al., 1986); (b) the two nucleat- 
ing activities are different  in that Ca  2+ promotes nucleation 
by intact gelsolin but not by CT45N,  and PIP2 inhibits  the 
latter  more potently  (Janmey  and  Stossel,  1987); (c) Ca  2§ 
has no effect on CT45N binding to actin but PIP2 does; (d) 
Ca  2+ is required  for CT38C binding to actin, but PIP2 has 
no effect. Therefore, it is reasonable to hypothesize that oc- 
cupation of the COOH-terminal actin binding domain is re- 
quired for optimal nucleation. Additional NH2-terminal  do- 
main must also be involved however, since CT38C does not 
by itself promote nucleation (Kwiatkowski et al.,  1985). 
The question of which of the three currently identified ac- 
tin binding sites are involved in capping of the barbed  end 
of the filament is also not resolved. The actin  filament end 
blocking function of gelsolin is most resistent to inhibition 
by  PIP2,  and also has the least stringent  requirement for 
Ca  2+ (Janmey  et al.,  1985)  when compared with severing 
and nucleation. In this paper, we have shown that binding of 
isolated CT14N and CT38C to actin are relatively more resis- 
tant to inhibition by PIP2 than C'q28N, so actin binding sites 
located in those peptides may contribute to PIP2-resistant 
capping observed at steady state. PIP2 however does appear 
to have some effect on the capping process, because it can 
temporarily allow elongation of actin filaments off the barbed 
ends of gelsolin-capped filaments (Janmey  et al.,  1987). 
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